A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
PHASE3
This Phase III, double-blind, placebo and active-comparator controlled, mul...
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
PHASE3
Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, s...
Status
Completed
Location
AZ Arthritis and Rheumotology Research, PLLC - Flagstaff /ID# 253431
Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
PHASE3
The objective of this study is to assess the efficacy and safety of adalimu...
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
PHASE3
This study includes two periods. The main objective of Period 1 is to compa...
Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
PHASE3
The primary objective of this study is to evaluate the effects of filgotini...